During the day the stock fluctuated 13.80% from a day low at $9.27 to a day high of $10.55. 1. View analysts' price targets for Trillium Therapeutics or view top-rated stocks among Wall Street analysts. Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Want to see which stocks are moving? Investors can use this forecasting interface to forecast Trillium Therapeutic historical stock prices and determine the direction of Trillium Therapeutic's future trends based on various well-known forecasting models. Question Box: Frequently Asked Questions for TRANSFORMERS & RECTIFIERS IN stock Is TRANSFORMERS & RECTIFIERS IN a good long term stock? The consensus among Wall Street equities research analysts is that investors should "buy" Trillium Therapeutics stock. Help us improve our free forecast service with share! Trillium Therapeutics Inc. (TRIL) shares are trading at higher $14.57 and the avg recommendation for the stock is Strong Buy, while the current analyst price target stands at $11.02. NSE stock TRIL Transformers And forecast & share price targets are below. Trillium Therapeutics' management team includes the following people: C.P.A., MAcc, CPA-CA, Chief Financial Officer, Start Your Risk-Free Trial Subscription Here, Li Auto Stock is a Top EV Play to Consider, Fuel Tech: A Small Play on a Big Pollution Market, Why These 3 Stocks are Leading the Dow Higher, Lennar Stock Struggles For Direction After Earnings Blowout, Kopin Stock is a Transformative AR/VR Component Play, Starbucks Stock Back To All Time Highs With More To Come, Raymond James Financial Stock May Be Forming Flat Base, Soaring Eagle Stock is a SPAC Opportunity with a Track Record, 7 Stocks That Cathie Wood is Buying And You Should Too, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, Trillium Flow Technologies™ acquires Red Point Alloys BV, Trillium Therapeutics is Now Oversold (TRIL), Trillium Therapeutics: A Potentially Undervalued CD47 Player, The Worst Mistake Trillium Investors Can Make Right Now, Red-Hot Biotechs to Take Center Stage at Blood Disorder Meeting, Trillium Therapeutics to Present Clinical Data at the 62nd American Society of Hematology Annual Meeting, Trillium Therapeutics Appoints Michael Kamarck, Ph.D., to Its Board of Directors, Trillium (TRIL) Soars: Stock Adds 6% in Session, Trillium Prices Public Offering At $13/Share; Street Bullish, Why Trillium's Stock Is Trading Higher Today, Trillium Announces Pricing of US$130 Million Public Offering of Common Shares, The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment, Encouraging data on blood cancer candidates lifts Trillium, up 40%, After Hours Market: Trillium, Superconductor Gain; Coupa Software, Slack Technologies, Vroom Slip, Trillium Therapeutics: Recent Weakness Presents a Buying Opportunity, Says 5-Star Analyst, view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. The long-term earning potential is USD today. index on US Stock Market : At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Trillium Therapeutics Inc (TRIL). With a 5-year investment, the revenue is Learn everything you need to know about successful options trading with this three-part video course. The biotechnology company reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.25) by $0.33. TRIL expected stock price. 22.679 USD in Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. 2022 is 18.2971622365173 tril $12.03 $0.30 2.6% Price as of March 12, 2021, 9:00 p.m. EST View Interactive TRIL Charts They missed their target on earnings by a... I’m very excited about the possibilities for this stock. 68.595 USD . Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. justaninvestor — Get short term trading ideas from the MarketBeat Idea Engine. Our Accessibility Statement According to our analysis, this will not happen. QQQ 315.46 (-0.81%) Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Trillium Therapeutics has received 301 “outperform” votes. Trillium Therapeutics has received 58.45% “outperform” votes from our community. One share of TRIL stock can currently be purchased for approximately $10.79. TRIL stock forecast. View TRIL's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. The prediction is based on 8 analyst estimates. The stock is rated as a Hold by none analyst(s), 7 recommend it as a Buy and 1 called the TRIL stock Outperform. Will TRIL price drop? See what's happening in the market right now with MarketBeat's real-time news feed. Vote “Underperform” if you believe TRIL will underperform the S&P 500 over the long term. Trillium Therapeutics Inc finance tips, Is Trillium Therapeutics Inc a profitable investment? Analyzing Trillium Therapeutics (NASDAQ:TRIL) stock? TRIL Stock Predictions - Get a free TRIL stock forecast with the trend analysis tool. Stocks ; Trillium Therapeutics: A Small-Cap Biotech Stock Loved By Hedge Funds. Long. View insider buying and selling activity for Trillium Therapeutics or view top insider-selling stocks. investment rating Trillium Therapeutics Inc. was founded in 2004 is headquartered in Mississauga, Canada. Find the latest Earnings Report Date for Trillium Therapeutics Inc. Common Shares (TRIL) at Nasdaq.com. How will Trillium Therapeutics Inc stock price increase? TRIL prediction, Trillium Therapeutics stock forecast & analyst price target predictions based on 1 analysts offering 12-months price targets for TRIL in the last 3 months. ; Trillium Therapeutics Inc has risen higher in 7 of those 16 years over the subsequent 52 week period, corresponding to a historical accuracy of 43.75 % ; Is Trillium Therapeutics Inc Stock Undervalued? TRIL Stock Predictions TRIL Stock Predictions. TRIL: Ascending Triangle, Confirmed. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The biotechnology company earns $-41,620,000.00 in net income (profit) each year or ($1.38) on an earnings per share basis. Trillium Therapeutics has received a consensus rating of Buy. Texas Gulf Energy, Incorporated (TXGE) Stock Forecast, Fujian Blue Hat Interactive Entertainment Technology Ltd (BHAT) Stock Forecast, PT Media Nusantara Citra Tbk (MNCN) Stock Forecast, Leo Holdings Corp. Units each consisting of one Class A ordinary share and one-third of one redeemable warrant (LHC-U) Stock Forecast, SSgA Active Trust - SSgA Financial Select Sector SPDR (XLF) Stock Forecast, IDFC First Bank Ltd (IDFCFIRSTB) Stock Forecast, > Page 2: detailed data / stock price table <, CarLotz Inc - Class A Stock Forecast, "LOTZ" Share Price Prediction Charts, AMC Entertainment Holdings Inc - Class A Stock Forecast, "AMC" Share Price Prediction Charts, Cheesecake Factory Stock Forecast, "CAKE" Share Price Prediction Charts, Enzolytics Stock Forecast, "ENZC" Share Price Prediction Charts, Data Trillium Therapeutics Inc stock forecast, TRIL forecast, Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. year. Their forecasts range from $14.00 to $28.00. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Trillium (TRIL) Soars: Stock Adds 6% in Session 09/15/20-7:38AM EST Zacks New Strong Sell Stocks for August 17th 08/17/20-8:14AM EST Zacks. To see all exchange delays and terms of use please see disclaimer. (Add your “outperform” vote. Looking for new stock ideas? Find out now. Please log in to your account or sign up in order to add this asset to your watchlist. +108.45% Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). See above. Is Trillium Therapeutics Inc price going up? Your "Ai... Why in the search bar Wallet Investors keeps changing the Name of AMC Entertainment with Arizona Metals AMC? View Trillium Therapeutics' earnings history. According to 7 analysts, the average rating for TRIL stock is "Strong Buy." LeLaf. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. In the past three months, Trillium Therapeutics insiders have sold more of their company's stock than they have bought. Trillium Therapeutics trades on the NASDAQ under the ticker symbol "TRIL.". High institutional ownership can be a signal of strong market trust in this company. Trillium Therapeutics is headquartered at 2488 DUNWIN DRIVE, MISSISSAUGA A6, L5L 1J9. View real-time stock prices and stock quotes for a full financial overview. allawi. Based on aggregate information from My MarketBeat watchlists, some companies that other Trillium Therapeutics investors own include Inovio Pharmaceuticals (INO), SCYNEXIS (SCYX), Sorrento Therapeutics (SRNE), TG Therapeutics (TGTX), Energy Transfer (ET), Gilead Sciences (GILD), VBI Vaccines (VBIV), Agile Therapeutics (AGRX), Actinium Pharmaceuticals (ATNM) and Evoke Pharma (EVOK). significantly excessive / unrealistic! However, solely looking at the historical price movement is usually misleading. View all of TRIL's competitors. Trillium Therapeutics has a market capitalization of $1.11 billion and generates $120,000.00 in revenue each year. Investors can use this forecasting interface to forecast TRANSFORMERS AND historical stock prices and determine the direction of TRANSFORMERS AND RECTIFIERS's future trends based on various well-known forecasting models. What this means: Trillium Therapeutics Inc (TRIL) gets an Overall Rank of 67, which is an above average rank under InvestorsObserver's stock ranking system. According to . Trillium Therapeutics does not have a long track record of dividend growth. View Trillium Therapeutics Inc. TRIL investment & stock information. Trillium Therapeutics Inc quote is equal to 10.880 USD at 2021-03-17. Term Box: (Add your “underperform” vote.). The company's lead program is TTI-621, a SIRPaFc fusion protein that acts a soluble decoy receptor preventing CD47 from delivering its inhibitory signal, which is in Phase I clinical trial for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The TRIL ("TRIL" ) Yes. 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Trillium Therapeutics in the last year. This is 2.15% less than the trading day before Thursday, 4th Mar 2021. Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. TRIL -- USA Stock : USD 12.03 0.30 2.56% : Trillium Therapeutic Stock Forecast is based on your current time horizon. Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. TRIL stock price prediction, Over the last 52 weeks, […] Its product candidates also include TTI-622 that is in Phase I clinical trial of immunoglobulin G4 SIRPaFc protein; and TTI-10001, a small molecule stimulator of interferon genes agonist that senses cytosolic DNA for promoting tumor immunity, which is in the discovery Phase. Trillium Therapeutics' stock is owned by many different retail and institutional investors. 100% Free, Limited Time Only! Sign-up to receive the latest news and ratings for TRIL and its competitors with MarketBeat's FREE daily newsletter. TRIL Stock Chart. Find real-time TRIL - Trillium Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. To add more color to this target, the company’s high over the last year is $16.89 and the low is $0.24. Export data to Excel for your own analysis. Receive a free world-class investing education from MarketBeat. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Below you will find the price predictions for 2021, 2022, 2023, 2024, 2025, 2026. the "TRIL" stock price prognosis for 2026-03-13 is 68.595 USD. View institutional ownership trends for Trillium Therapeutics. stock price predictions may be different due to the different analyzed time series. The 12-month stock price forecast is 11.02, which is a decrease of -8.40% from the latest price. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Your "Ai... mayris1st — Earnings for Trillium Therapeutics are expected to grow in the coming year, from ($2.42) to ($0.45) per share. The P/E ratio of Trillium Therapeutics is -4.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. TRIL forecast tomorrow, These share price targets & forecast are valid from short-term to mid-term to long-term. Wall Street analysts have given Trillium Therapeutics a "Buy" rating, but there may be better short-term opportunities in the market. 5 Wall Street analysts have issued twelve-month price targets for Trillium Therapeutics' stock. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. TRANSFORMERS AND Stock Forecast is based on your current time horizon. When will TRIL stock price go down? Trillium Therapeutics Inc. (NASDAQ:TRIL) issued its quarterly earnings data on Sunday, November, 15th. 3. Chart for TRIL. All rights reserved. In order for the stock price to hit the forecast high, the stock would need to surge +148.23% from its current level, while the stock would need to crash 24.11% from its … Is TRIL stock price going to drop? There are currently 1 hold rating and 4 buy ratings for the stock. Policy, Trillium Therapeutics Inc Stock Price Forecast for 2021, Trillium Therapeutics Inc Stock Price Forecast for 2022, Trillium Therapeutics Inc Stock Price Forecast for 2023, Trillium Therapeutics Inc Stock Price Forecast for 2024, Trillium Therapeutics Inc Stock Price Forecast for 2025, Trillium Therapeutics Inc Stock Price Forecast for 2026. Trillium Therapeutics has received no research coverage in the past 90 days. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. The low price target for TRIL is $14.00, while the high price target is $28.00. The Ticker name says... why is the price of CAKE keep going up, when restaurants are going out of business everywhere. Will TRIL stock price rise? Your current $100 investment may be up to $630.47 in 2026. Price Target Trillium Therapeutics (TRIL) stock price prediction is 25.992688 USD. Not within a year. At that level, TRIL’s share price would be +131.7% above current price. You can opt out at any time. Top institutional shareholders include Avoro Capital Advisors LLC (5.64%), Avidity Partners Management LP (3.09%), Frazier Management LLC (2.97%), Orbimed Advisors LLC (2.88%), Artal Group S.A. (2.04%) and Laurion Capital Management LP (0.97%). Get daily stock ideas top-performing Wall Street analysts. Trillium Therapeutics Inc market prognosis, View which stocks have been most impacted by COVID-19. Be professionals !! This page states Carlotz forecasted earnings growth will be minus 100% for next year, minus 100% for 2023, and minus 100% for 2026? Do Not Sell My Information. Trillium Therapeutics Inc (TRIL:TOR) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. I’m very excited about the possibilities for this stock. why is the price of CAKE keep going up, when restaurants are going out of business everywhere. TRIL stock was sold by a variety of institutional investors in the last quarter, including PFM Health Sciences LP, Renaissance Technologies LLC, ExodusPoint Capital Management LP, Pura Vida Investments LLC, Acuta Capital Partners LLC, Blair William & Co. IL, Vident Investment Advisory LLC, and Chartwell Investment Partners LLC. Fundamental company data provided by Zacks Investment Research. Date Range. Shares of TRIL can be purchased through any online brokerage account. TRIL stock was acquired by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC, Avidity Partners Management LP, Artal Group S.A., Laurion Capital Management LP, Columbus Circle Investors, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Avoro Capital Advisors LLC, and Tri Locum Partners LP. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Based on TRIL analyst price targets, TRIL stock forecast is $22.00 (for a year from now). Think we've hit the bottom, looking to go to $20, possibly $27 if it can break the next major resistance. You may vote once every thirty days. Identify stocks that meet your criteria using seven unique stock screeners. Register. Analyst projections state that TRIL is forecast to be at a low of $14 and a high of $28. Short-term and long-term TRIL (Trillium Therapeutics Inc) Trillium Therapeutics' stock was trading at $5.19 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). from View our full suite of financial calendars and market data tables, all for free. expected to be around +530.47%. Trillium Therapeutics Inc Stock Forecast. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. TRIL Stock Analysis Overview What this means: Trillium Therapeutic (TRIL) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. MarketBeat just released five new trading ideas, but Trillium Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Compare Top Brokerages Here. The trend analysis tool will help you make a better prediction on the TRIL stock. If you are looking for stocks with good return, Trillium Therapeutics Inc can be a profitable investment option. The Trillium Therapeutics stock price is Trillium Therapeutics Inc projections, * Our share forecasts and predictions are made by, Trillium Therapeutics Inc Forecast. one According to AI Pickup, the TRANSFORMERS & RECTIFIERS IN stock price forecast for Mar. Investors will be thrilled if TRIL’s share price rises to $25, which is the median consensus price. Should I buy or sell TRIL? This page states Carlotz forecasted earnings growth will be minus 100% for next year, minus 100% for 2023, and minus 100% for 2026? When will Trillium Therapeutics Inc price drop? Learn more. The Ticker name says... doronhaen_7519 — The biotechnology company can be reached via phone at 416-595-0627 or via email at [email protected]. Company insiders that own Trillium Therapeutics stock include James T Parsons, Jan Skvarka, Penka Petrova and Robert Uger. This suggests a possible upside of 96.9% from the stock's current price. View analyst ratings for Trillium Therapeutics or view top-rated stocks. Specifically, they have bought $0.00 in company stock and sold $661,672.00 in company stock. Will Trillium Therapeutics Inc stock price fall? Vote “Outperform” if you believe TRIL will outperform the S&P 500 over the long term. Learn more. Trillium Therapeutics Inc. (TRIL) stock forecast and price target. The TRIL stock price can go up The current price is about 29.75% off the estimated low and 159.5% off the forecast high, based on this estimate. Trillium Therapeutics Inc technical analysis, TRIL, 1D. TRIL | Complete Trillium Therapeutics Inc. stock news by MarketWatch. TRIL, D. Long. TRIL Stock Analysis Overview . That means the average analyst price target for TRIL stock is $22.00. What is TRIL stock forecast (i.e., prediction)? Trillium Therapeutics' mailing address is 2488 DUNWIN DRIVE, MISSISSAUGA A6, L5L 1J9. 10.880 Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Trillium Therapeutics Stock Forecast, TRIL stock price prediction. 3. Trillium Therapeutics does not currently pay a dividend. Historical Some companies that are related to Trillium Therapeutics include Reata Pharmaceuticals (RETA), ACADIA Pharmaceuticals (ACAD), Hutchison China MediTech (HCM), PTC Therapeutics (PTCT), Nektar Therapeutics (NKTR), ChemoCentryx (CCXI), I-Mab (IMAB), Insmed (INSM), Apellis Pharmaceuticals (APLS), Hypera (HYPMY), Arvinas (ARVN), Agios Pharmaceuticals (AGIO), Rocket Pharmaceuticals (RCKT), Legend Biotech (LEGN) and InnovAge (INNV). Find the latest Trillium Therapeutics Inc. (TRIL) stock quote, history, news and other vital information to help you with your stock trading and investing. Why in the search bar Wallet Investors keeps changing the Name of AMC Entertainment with Arizona Metals AMC? MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View insider buying and selling activity for Trillium Therapeutics or or view top insider-buying stocks. Check if TRIL has a Buy or Sell Evaluation. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Close price at the end of the last trading day (Friday, 5th Mar 2021) of the TRIL stock was $10.03. Should I buy or sell TRIL stock? On average, they anticipate Trillium Therapeutics' stock price to reach $21.25 in the next twelve months. The official website for Trillium Therapeutics is www.trilliumtherapeutics.com. Trillium Therapeutics Inc Stock Price Forecast, "TRIL" Predictons for2021 Since then, TRIL shares have increased by 107.9% and is now trading at $10.79. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Over the next 52 weeks, Trillium Therapeutics Inc has on average historically risen by 60.4 % based on the past 16 years of stock performance. Biotech stocks have grabbed the attention of many investors in the last couple of months as the fight against Covid-19 continued to gain traction. in one year. TRIL stock price predictions 2021, Will TRIL price go up? Learn about financial terms, types of investments, trading strategies and more. A high-level overview of Trillium Therapeutics Inc. (TRIL) stock.
Boroondara Spydus Login, Bednarek Fifa 19, What Is Yo-yo Test In Cricket, Haddonfield Candlelight Shopping 2020, Rust Test Result,